1 option
CADTH Canadian Drug Expert Review Committee final recommendation : indication: pulmonary arterial hypertension. Riociguat (Adempas - Bayer HealthCare Inc.) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Language:
- English
- Subjects (All):
- Outcome assessment (Medical care).
- Physical Description:
- 1 online resource (6 pages) : illustrations
- Place of Publication:
- Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2015.
- Summary:
- The CADTH Canadian Drug Expert Review Committee (CDEC) recommends that riociguat be listed for the treatment of pulmonary arterial hypertension.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.